Illumina, Inc.

As a startup, Illumina aspired to transform human health. Our initial products enabled researchers to explore DNA at an entirely new scale, helping them create the first map of gene variations associated with health, disease, and drug response. Every breakthrough opened up a new world, and showed us how much further there is to go.Today we are a global leader in genomics – an industry at the intersection of biology and technology. At the most fundamental level, we enable our customers to read and understand genetic variations. We strive to make our solutions increasingly simple, more accessible, and always reliable. As a result, discoveries that were unimaginable even a few years ago are now becoming routine – and are making their way into patient treatment.

Bank Name Illumina, Inc.
Stock Exchange NASDAQ
Symbol ILMN
Sector Healthcare
Industry Biotechnology: Laboratory Analytical Instruments
Country United States
World Region Amarica
Chairman Mr. Jay T. Flatley
CEO Mr. Francis A. deSouza
Employees 6200
Registered Year 1998